Pancreatic Cancer Clinical Trials in Baltimore

Showing 81-100 of 104 trials

Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer

NCT01895790

This research is being done to assess the effects of pancreatic duct stenting on relief of obstructive pain (pain due to outflow obstruction of main pancreatic duct) caused by pancreatic cancer.

Pancreatic Cancer

Johns Hopkins UniversityStarted Jul 2014

Baltimore, Maryland, United States

COMPLETEDPHASE2< 1 mile

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

NCT00499486

RATIONALE: Sirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well sirolimus works in treating patients with advanced pancreatic cancer.

Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins47 participantsStarted Jan 2005

Baltimore, Maryland, United States

COMPLETEDPHASE2< 1 mile

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

NCT00003546

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine plus radiation therapy in treating patients with pancreatic cancer that cannot be removed surgically.

Pancreatic Cancer

Alliance for Clinical Trials in Oncology43 participantsStarted Sep 1998

Birmingham, Alabama, United States • La Jolla, California, United States • San Francisco, California, United States +45 more locations

Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

Pancreatic Cancer Trials in Other Cities

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer

A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Other Conditions in Baltimore